Andrew E. Ajani

Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial

Shamir R. Mehta, Jean‐François Tanguay, John W. Eikelboom et al. · The Lancet · 2010 · 824 citations

Percutaneous Coronary Intervention, Thrombosis, Cardiovascular Disease +14

Major noncardiac surgery following coronary stenting: When is it safe to operate?

Arvind Sharma, Andrew E. Ajani, Shadi M. Hamwi et al. · Catheterization and Cardiovascular Interventions · 2004 · 208 citations

Heart Failure, Endovascular Technique, Surgery +21

Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial

Markus P. Schlaich, M Bellet, Michael A. Weber et al. · The Lancet · 2022 · 206 citations · Full text

Molecular Pharmacology, Hypertension, Resistant Hypertension +9

Five-Year Follow-Up After Intracoronary Gamma Radiation Therapy for In-Stent Restenosis

Ron Waksman, Andrew E. Ajani, Robert L. White et al. · Circulation · 2004 · 186 citations · Full text

Prolonged Antiplatelet Therapy to Prevent Late Thrombosis After Intracoronary γ-Radiation in Patients With In-Stent Restenosis

Ron Waksman, Andrew E. Ajani, R. Larry White et al. · Circulation · 2001 · 177 citations · Full text